James Hardie Industries (JHX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Jul, 2026Executive summary
Completed acquisition of AZEK Company in July 2025, creating a $5B leader in home exteriors and outdoor living materials, with integration ahead of schedule and strong customer demand for expanded offerings.
Fiscal 2026 financial highlights: $4.8B net sales, $590M cash from operations, $104M net income, $1.3B adjusted EBITDA, and $314M free cash flow.
Board and management focused on delivering strategic commitments, rebuilding shareholder trust, and aligning governance with U.S. market practices as over 50% of shareholders are now U.S.-domiciled.
Voting matters and shareholder proposals
Shareholders to vote on director elections/re-elections, say-on-pay frequency, executive compensation, CEO equity grant, director equity plan, increase to director fee pool, financial statements, auditor ratification, and amendments to classified board provisions.
Board recommends annual say-on-pay votes and supports all proposals except for the director fee pool, where directors abstain from recommendation due to personal interest.
Proposal to amend Articles to apply classified board provisions to all directors, including the CEO, aligning with U.S. governance standards.
Board of directors and corporate governance
Board comprises eight non-executive directors (including Chair) and one executive director (CEO), with recent refreshment and new appointments to enhance diversity and expertise.
All standing committees are 100% independent; Chair is independent; board skills matrix reviewed annually to ensure alignment with strategic needs.
Board established an Integration & Performance Committee to oversee AZEK integration and company performance.
Shareholder engagement is ongoing, with robust year-round programs and direct input into governance and compensation decisions.
Latest events from James Hardie Industries
- Record Q1 EBITDA and 4% sales growth achieved; FY25 guidance reaffirmed amid market headwinds.JHX
Q1 20258 Jul 2026 - Director elections, say-on-pay, auditor ratification, and governance amendments up for vote.JHX
Proxy filing1 Jul 2026 - Major acquisition, board refresh, and executive pay overhaul highlight FY26 governance and strategy.JHX
Proxy filing18 Jun 2026 - AZEK acquisition and synergy gains drove strong sales and EBITDA growth, with FY27 targets raised.JHX
Q4 202620 May 2026 - Net sales up 30% to $1.24B, with higher EBITDA and raised FY26 guidance amid synergy progress.JHX
Q3 202613 Apr 2026 - Q2 FY26 sales jumped 34% on AZEK deal; margins fell, but FY26 outlook and synergies improved.JHX
Q2 20263 Feb 2026 - H1 EBITDA topped $500m, FY25 guidance and buybacks raised despite lower sales.JHX
Q2 202514 Jan 2026 - FY25 met guidance; AZEK deal to drive $500M synergies; FY26 targets sales, EBITDA, and cash flow growth.JHX
Q4 202514 Jan 2026 - Q3 FY25 delivered resilient margins, reaffirmed growth plans, and launched a new buyback program.JHX
Q3 20258 Jan 2026